Use Options For a Chance To Buy PCRX at a 25% Discount

Looking back to 31 days ago, Pacira Pharmaceuticals (PCRX) priced a 1,600,000 share secondary stock offering at $64.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Friday, the stock is now 13.8% above the offering price..